Month: November 2017

Read the Fabry Outcome Survey Annual Report 2017. About FOS The Fabry Outcome Survey (FOS) is a large, global, multicentre, observational registry, sponsored by Shire, for patients with Fabry disease. The registry was established in 2001 with the aim of collecting real-world data on the long-term safety and effectiveness of enzyme replacement therapy (ERT) with … Continue reading “Latest Fabry Outcome Survey report published”